Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse.

Artaza JN, Reisz-Porszasz S, Dow JS, Kloner RA, Tsao J, Bhasin S, Gonzalez-Cadavid NF.

J Endocrinol. 2007 Jul;194(1):63-76.

2.

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.

Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ, Gonzalez-Cadavid NF.

Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E876-88. Epub 2003 Jun 24.

3.

Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation.

McKoy G, Bicknell KA, Patel K, Brooks G.

Cardiovasc Res. 2007 May 1;74(2):304-12. Epub 2007 Feb 24.

4.

Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass.

Magee TR, Artaza JN, Ferrini MG, Vernet D, Zuniga FI, Cantini L, Reisz-Porszasz S, Rajfer J, Gonzalez-Cadavid NF.

J Gene Med. 2006 Sep;8(9):1171-81.

PMID:
16810717
5.

Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.

Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ.

J Cell Physiol. 1999 Jul;180(1):1-9.

PMID:
10362012
6.

Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes.

Shyu KG, Ko WH, Yang WS, Wang BW, Kuan P.

Cardiovasc Res. 2005 Dec 1;68(3):405-14. Epub 2005 Aug 25.

7.

Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells.

Artaza JN, Bhasin S, Mallidis C, Taylor W, Ma K, Gonzalez-Cadavid NF.

J Cell Physiol. 2002 Feb;190(2):170-9.

PMID:
11807821
8.

Myostatin regulates cell survival during C2C12 myogenesis.

RĂ­os R, Carneiro I, Arce VM, Devesa J.

Biochem Biophys Res Commun. 2001 Jan 19;280(2):561-6.

PMID:
11162556
9.

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.

Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC.

Circulation. 2007 Apr 10;115(14):1885-94. Epub 2007 Mar 26.

10.

Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction.

Matsunaga S, Okigaki M, Takeda M, Matsui A, Honsho S, Katsume A, Kishita E, Che J, Kurihara T, Adachi Y, Mansukhani A, Kobara M, Matoba S, Tatsumi T, Matsubara H.

J Mol Cell Cardiol. 2009 May;46(5):663-73. Erratum in: J Mol Cell Cardiol. 2009 Sep;47(3):419. Matoba, Yoshiaki [corrected to Matoba, Satoaki]; Jishan, Che [corrected to Che, Jishan].

PMID:
19358330
11.

Transgenic salmon overexpressing growth hormone exhibit decreased myostatin transcript and protein expression.

Roberts SB, McCauley LA, Devlin RH, Goetz FW.

J Exp Biol. 2004 Oct;207(Pt 21):3741-8.

12.

Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.

Seyed M, Dimario JX.

J Mol Cell Cardiol. 2008 Mar;44(3):510-9. doi: 10.1016/j.yjmcc.2007.12.008. Epub 2008 Jan 17.

PMID:
18275970
13.

Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat.

Dasarathy S, Dodig M, Muc SM, Kalhan SC, McCullough AJ.

Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1124-30. Epub 2004 Jul 15.

14.

Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.

Rajagopalan V, Zucker IH, Jones JA, Carlson M, Ma YJ.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H543-54. doi: 10.1152/ajpheart.91436.2007. Epub 2008 Jul 3.

15.

Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.

Niizeki T, Takeishi Y, Kitahara T, Arimoto T, Ishino M, Bilim O, Suzuki S, Sasaki T, Nakajima O, Walsh RA, Goto K, Kubota I.

Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H245-55. doi: 10.1152/ajpheart.00066.2008. Epub 2008 May 16.

16.

PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility.

Jeong D, Cha H, Kim E, Kang M, Yang DK, Kim JM, Yoon PO, Oh JG, Bernecker OY, Sakata S, Le TT, Cui L, Lee YH, Kim do H, Woo SH, Liao R, Hajjar RJ, Park WJ.

Circ Res. 2006 Aug 4;99(3):307-14. Epub 2006 Jun 29.

17.

Functional analysis of the Myostatin gene promoter in sheep.

Du R, An X, Chen Y, Qin J.

Sci China C Life Sci. 2007 Oct;50(5):648-54.

PMID:
17879064
18.

Skeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGF-beta family signaling.

Nomura T, Ueyama T, Ashihara E, Tateishi K, Asada S, Nakajima N, Isodono K, Takahashi T, Matsubara H, Oh H.

Biochem Biophys Res Commun. 2008 Jan 25;365(4):863-9. Epub 2007 Nov 29.

PMID:
18047832
19.

Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.

Evans-Anderson HJ, Alfieri CM, Yutzey KE.

Circ Res. 2008 Mar 28;102(6):686-94. doi: 10.1161/CIRCRESAHA.107.163428. Epub 2008 Jan 24.

20.

Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.

Li L, Okada H, Takemura G, Kosai K, Kanamori H, Esaki M, Takahashi T, Goto K, Tsujimoto A, Maruyama R, Kawamura I, Kawaguchi T, Takeyama T, Fujiwara T, Fujiwara H, Minatoguchi S.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1504-13. doi: 10.1152/ajpheart.00194.2009. Epub 2009 Aug 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk